Bank of New York Mellon’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,591
| Closed | -$6.59K | – | 4272 |
|
|
2025
Q2 | $6.59K | Buy |
14,591
+1
| +0% | – | ﹤0.01% | 4132 |
|
|
2025
Q1 | $5.94K | Sell |
14,590
-1
| -0% | -$1 | ﹤0.01% | 4109 |
|
|
2024
Q4 | $9.66K | Buy |
14,591
+1
| +0% | +$1 | ﹤0.01% | 4111 |
|
|
2024
Q3 | $12.4K | Hold |
14,590
| – | – | ﹤0.01% | 4078 |
|
|
2024
Q2 | $9.74K | Hold |
14,590
| – | – | ﹤0.01% | 4100 |
|
|
2024
Q1 | $19K | Sell |
14,590
-42,801
| -75% | -$44.8K | ﹤0.01% | 4114 |
|
|
2023
Q4 | $32.9K | Hold |
57,391
| – | – | ﹤0.01% | 4196 |
|
|
2023
Q3 | $43.3K | Sell |
57,391
-74
| -0.1% | -$56 | ﹤0.01% | 4177 |
|
|
2023
Q2 | $42K | Sell |
57,465
-391,581
| -87% | -$364K | ﹤0.01% | 4204 |
|
|
2023
Q1 | $340K | Sell |
449,046
-928
| -0.2% | -$862 | ﹤0.01% | 3687 |
|
|
2022
Q4 | $432K | Sell |
449,974
-15,672
| -3% | -$22.1K | ﹤0.01% | 3614 |
|
|
2022
Q3 | $1.01M | Buy |
465,646
+42,535
| +10% | +$147K | ﹤0.01% | 3197 |
|
|
2022
Q2 | $1.48M | Sell |
423,111
-5,998
| -1% | -$22.4K | ﹤0.01% | 2999 |
|
|
2022
Q1 | $2.16M | Buy |
429,109
+22
| +0% | +$111 | ﹤0.01% | 2887 |
|
|
2021
Q4 | $2.69M | Buy |
429,087
+5,422
| +1% | +$37K | ﹤0.01% | 2812 |
|
|
2021
Q3 | $3.37M | Buy |
423,665
+38,682
| +10% | +$318K | ﹤0.01% | 2703 |
|
|
2021
Q2 | $2.88M | Buy |
384,983
+95,432
| +33% | +$666K | ﹤0.01% | 2773 |
|
|
2021
Q1 | $1.75M | Sell |
289,551
-5,504
| -2% | -$42.3K | ﹤0.01% | 2994 |
|
|
2020
Q4 | $1.69M | Buy |
295,055
+132,179
| +81% | +$841K | ﹤0.01% | 2945 |
|
|
2020
Q3 | $1.08M | Buy |
162,876
+38,072
| +31% | +$339K | ﹤0.01% | 3081 |
|
|
2020
Q2 | $1.1M | Buy |
124,804
+83,096
| +199% | +$239K | ﹤0.01% | 3049 |
|
|
2020
Q1 | $74K | Buy |
+41,708
| New | +$53.1K | ﹤0.01% | 3907 |
|
|
2018
Q1 | – | Sell |
-1,484
| Closed | -$9K | – | 4417 |
|
|
2017
Q4 | $9K | Buy |
1,484
+154
| +12% | +$1.08K | ﹤0.01% | 4336 |
|
|
2017
Q3 | $10K | Hold |
1,330
| – | – | ﹤0.01% | 4240 |
|
|
2017
Q2 | $10K | Sell |
1,330
-372
| -22% | -$2.22K | ﹤0.01% | 4267 |
|
|
2017
Q1 | $13K | Buy |
1,702
+372
| +28% | +$3.81K | ﹤0.01% | 4248 |
|
|
2016
Q4 | $18K | Sell |
1,330
-105
| -7% | -$1.6K | ﹤0.01% | 4224 |
|
|
2016
Q3 | $30K | Sell |
1,435
-304
| -17% | -$4.81K | ﹤0.01% | 4191 |
|
|
2016
Q2 | $27K | Buy |
1,739
+166
| +11% | +$2.76K | ﹤0.01% | 4249 |
|
|
2016
Q1 | $26K | Hold |
1,573
| – | – | ﹤0.01% | 4156 |
|
|
2015
Q4 | $34K | Sell |
1,573
-9
| -0.6% | -$198 | ﹤0.01% | 4233 |
|
|
2015
Q3 | $34K | Buy |
1,582
+9
| +0.6% | +$218 | ﹤0.01% | 4286 |
|
|
2015
Q2 | $36K | Buy |
1,573
+393
| +33% | +$9.65K | ﹤0.01% | 4190 |
|
|
2015
Q1 | $30K | Buy |
1,180
+59
| +5% | +$1.63K | ﹤0.01% | 4170 |
|
|
2014
Q4 | $28K | Buy |
1,121
+3
| +0.3% | +$77 | ﹤0.01% | 4191 |
|
|
2014
Q3 | $30K | Hold |
1,118
| – | – | ﹤0.01% | 4180 |
|
|
2014
Q2 | $35K | Buy |
1,118
+22
| +2% | +$919 | ﹤0.01% | 4101 |
|
|
2014
Q1 | $74K | Buy |
+1,096
| New | +$67.8K | ﹤0.01% | 4037 |
|
Other funds holding VXRT
XT
HSA
BCMLT
CFO
LCM
HWA
Bank of New York Mellon's VXRT Position: Q3 2025 in Review
Bank of New York Mellon sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 14,591 shares — an estimated $6.59K sold.
Bank of New York Mellon first reported a position in VXRT in Q1 2014 and held it in 38 quarters. The position peaked at $3.37M in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.
- Bank of New York Mellon reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
- Bank of New York Mellon sold 14,591 Vaxart shares in Q3 2025, an estimated $6.59K.
- Bank of New York Mellon first reported a position in Vaxart in Q1 2014 and held it in 38 quarters.
- Bank of New York Mellon's Vaxart position peaked at $3.37M in Q3 2021.
- 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.
Based on Bank of New York Mellon's 13F filing for Q3 2025, filed 3 Nov 2025.